BTAI icon

BioXcel Therapeutics

88 hedge funds and large institutions have $118M invested in BioXcel Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

less funds holding

Funds holding:

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

64% less capital invested

Capital invested by funds: $325M → $118M (-$207M)

Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.79M
Puts
$5.96M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$29.1M
2
$13.8M
3
$13M
4
$9.25M
5
$8.01M
6
$7.52M
7
$5.95M
8
$4.15M
9
$2.69M
10
$2.33M
11
$1.8M
12
$1.67M
13
$1.63M
14
$1.61M
15
$1.32M
16
$987K
17
$959K
18
$753K
19
$739K
20
$672K
21
$671K
22
$649K
23
$618K
24
$519K
25
$515K